Discovery of <i>trans</i>-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4<i>S</i>)-methoxy-(2<i>S</i>)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 AntagonistFumihito Muro, Nobuo Machinaga, Jun Chiba et al.|Journal of Medicinal Chemistry|2009Cited by 25
Improvement of Pulmonary Function by Oral Treatment with a VLA-4 Antagonist in a Mouse Asthmatic ModelGensuke Takayama, Tohru Takashi, Keiko Matsumoto et al.|Journal of Pharmacological Sciences|2013Cited by 3